Phase II Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2 (Primary)
- Indications Malignant melanoma; Renal cancer
- Focus Therapeutic Use
- 30 Apr 2020 Biomarkers information updated
- 21 May 2011 New trial record